The MJM Signature Group is pleased to announce the launch of Effectus, a clinical trial recruitment company which will join Spire Learning and CPE Communications as a new division.
Effectus has developed a unique approach to patient recruitment by working directly with targeted, pre-screened physicians who have signed on and are committed to the Effectus process. Their active engagement facilitates a high volume of qualified patients enrolling in clinical trials. The Effectus method will help to increase patient recruitment rates, thereby accelerating completion of clinical trials and enabling important drugs to come to market sooner.
“Through the work we have completed with CPE Communications and our colleagues in the healthcare industry, we have developed an in-depth understanding of the multiple challenges that clinical trial investigators face, the most limiting of which is patient recruitment,” said Chris Miller, VP of business development at MJM Signature Group. “Recruitment delays impact overall clinical trial timelines and impede access to needed new medications.”
MJM Signature Group